APACHE Medical Systems, Inc.

APACHE Medical Systems, Inc. (www.apache-msi.com)(Nasdaq:AMSI), is a recognized leader in clinical decision support/outcomes management systems and consulting services for the care of high-risk, high-cost patients in critical, acute, cardiovascular and HIV/AIDS care. Headquartered in McLean, Va., the company's products and services enable health systems, hospitals and providers to apply an evidence-based approach to achieve clinical performance excellence, reduce cost and compete effectively under managed care.

APACHE's Health Outcomes Research division serves government agencies, as well as the pharmaceutical and medical device industries with a variety of unique services.

For instance, a new APACHE® Simulator service line helps the drug and device industry cut clinical trial costs and boost effectiveness through the use of integrated APACHE clinical trial simulation services that simulate clinical trials on an advanced scale. APACHE uses proprietary computer models, databases and specialized inhouse expertise to help the industry speed FDA Approval and bring consumers safe, effective new therapies more quickly and affordably.

"Increased attention is now being paid to the use of technology to reduce medical errors," says APACHE CEO William A. Knaus, MD. "This is an ideal time to strive for 'evidence-based clinical trials,' too."

"With the Simulator, we can now apply internationally recognized APACHE 'Gold Standard' science to help the industry develop more precisely targeted new clinical therapies. It's a natural evolution of our company's strengths."

Knaus and new APACHE R& D Director Jack Zimmerman, MD, are internationally recognized critical care medicine and outcomes research experts.